Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
2.980
-0.150 (-4.79%)
Feb 21, 2025, 4:00 PM EST - Market closed
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $90.41 million as of February 21, 2025.
Market Cap
90.41M
Enterprise Value
23.19M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.98
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $90.41M, a decrease of -74.61%. That is a compound annual growth rate of -79.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 90.40M | 5.24% |
| Dec 31, 2024 | 85.90M | -75.88% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 783.00B |
| UnitedHealth Group | 465.53B |
| Johnson & Johnson | 384.41B |
| Novo Nordisk | 370.06B |
| AbbVie | 352.59B |
| Abbott Laboratories | 230.46B |
| AstraZeneca | 228.16B |
| Merck & Co. | 219.93B |